It has been reported that GLP-1 participates in the upregulation of the activity and protein expression of NOS in human umbilical vein endothelial cells [25] and improves endothelial dysfunction in patients with T2D and coronary heart disease [26]. This evidence concerns the gene GCG and coronary artery disorder.